Skip to main content
    W

    Werewolf Therapeutics Inc (HOWL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.99
    +0.01 (+1.07%)

    Market Cap: $47.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    76%(16/21)
    Avg Surprise
    +17.30%
    Streak
    5 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.17
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-164.80%Operating Margin-121.80%
    ROE-119.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.19xQuick Ratio1.19x
    Trading Statistics
    Beta0.55Avg Volume317.01K
    52-Week High$1.2052-Week Low$0.27

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 0.7% above its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 49.3, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.01
    SMA 20$1.02
    SMA 50$0.98
    SMA 200$0.70
    EMA 10$1.00
    EMA 20$1.00
    EMA 50$0.94
    EMA 200$0.81

    MACD

    Line: 0.01Signal: 0.02Hist: -0.01

    ADX

    ADX: 21.9+DI: 21.0-DI: 21.9

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down100.0
    PSAR$1.09

    Bollinger Bands

    Upper Band$1.10
    Lower Band$0.94
    %B Position1553%(Upper)
    Band Width0.32

    RSI (14-Day)

    Neutral
    49.3

    Momentum Oscillators

    Stoch %K20.6
    Stoch %D20.2
    Williams %R-72.8
    ROC (10d)-5.6%
    Momentum-0.06
    CCI (20d)-92.8
    MFI (14d)56.3

    Volatility Measures

    ATR (14d)$0.05(5.4%)
    StdDev (20d)0.04
    Hist Vol62.1%(High)

    Volume Flow

    VWAP$0.98
    OBV360.6M
    AD Line-234.5M
    CMF (20d)-0.006

    Volume Metrics

    Avg Vol (20d)313.9K
    Vol Ratio2.3x(High)
    VWMA (20d)$1.02

    Pivot Points

    R3$1.03
    R2$1.02
    R1$1.00
    Pivot Point$0.99
    S1$0.97
    S2$0.96
    S3$0.94

    Advanced Oscillators

    TSI2.99
    Ultimate Osc39.2
    KST45.36

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about HOWL

    News

    HOWL Valuation

    GNG's valuation label for HOWL is Undervalued.

    P/B
    7.1x
    All HOWL metrics

    HOWL Profitability: Margins, ROIC and FCF

    Werewolf Therapeutics (HOWL) has an operating margin of -121.8% and a net margin of -164.8%. It posts a -114.1% FCF margin.

    Operating margin
    -121.8%
    Net margin
    -164.8%
    ROE
    -119.9%
    FCF margin
    -114.1%
    HOWL financial statements

    Werewolf Therapeutics Competitors

    The companies most similar to Werewolf Therapeutics (HOWL) include Elicio Therapeutics, Plus Therapeutics and Oncolytics Biotech.

    Sector: Healthcare

    Companies most similar to Werewolf Therapeutics

    HOWL Bull Case vs Bear Case

    Bull case

    • HOWL beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • HOWL has a -164.8% net profit margin.
    • HOWL's quarterly revenue changed -100.0% year over year.

    HOWL Earnings: Beat Rate and Next Report

    Werewolf Therapeutics (HOWL) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 22, 2027.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    23.6%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.17
    HOWL earnings history

    HOWL Earnings Date

    HOWL reports Mar 22, 2027. The date is estimated.

    See insider activity

    Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About HOWL

    When does HOWL report earnings?

    Werewolf Therapeutics Inc (HOWL) is expected to report earnings on Mar 22, 2027.

    Does HOWL pay dividends?

    Werewolf Therapeutics Inc (HOWL) does not currently pay a regular dividend.

    What is HOWL's market cap?

    Werewolf Therapeutics Inc (HOWL) has a market capitalization of $47.64M with a current stock price of $0.99.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.